Abstract:ADVERTISEMENT RETURN TO ISSUEPREVAddition and Correct...Addition and CorrectionNEXTORIGINAL ARTICLEThis notice is a correctionCorrection to “Polymer-Mediated Drug Supersaturation Controlled by Drug–Polymer Interactions Persisting in an Aqueous Environment”Yuejie ChenYuejie ChenMore by Yuejie Chen, Yipshu PuiYipshu PuiMore by Yipshu Pui, Huijun ChenHuijun ChenMore by Huijun Chenhttp://orcid.org/0000-0003-0268-2976, Shan WangShan WangMore by Shan Wang, Peter SernoPeter SernoMore by Peter Serno, Wouter TonnisWouter TonnisMore by Wouter Tonnis, Linc ChenLinc ChenMore by Linc Chen, and Feng Qian*Feng QianMore by Feng Qianhttp://orcid.org/0000-0001-7415-6997Cite this: Mol. Pharmaceutics 2019, 16, 4, 1787Publication Date (Web):March 8, 2019Publication History Published online8 March 2019Published inissue 1 April 2019https://doi.org/10.1021/acs.molpharmaceut.9b00229Copyright © 2019 American Chemical SocietyRIGHTS & PERMISSIONSArticle Views843Altmetric-Citations-LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit PDF (206 KB) Get e-AlertsSUBJECTS:Supersaturation Get e-Alerts

Correction: Hallan et al. Challenges in the Physical Characterization of Lipid Nanoparticles. Pharmaceutics 2021, 13, 549

Correction: Synthetic Ultra-Long Chain Fatty Acyl Based Amphiphilic Lipids As a Dual Function Excipient for the Production of Surfactant-Free Solid Lipid Nanoparticles (Sf-Slns): a Physico-Chemical Study

Correction: Facile Preparation of Phospholipid-Amorphous Calcium Carbonate Hybrid Nanoparticles: Toward Controllable Burst Drug Release and Enhanced Tumor Penetration.

Correction: Yu et al. Achieving Effective Multimodal Imaging with Rare-Earth Ion-Doped CaF2 Nanoparticles. Pharmaceutics 2022, 14, 840

Correction: Supramolecularly Engineered Phospholipids Constructed by Nucleobase Molecular Recognition: Upgraded Generation of Phospholipids for Drug Delivery

Correction: A Novel Biocompatible, Simvastatin-Loaded, Bone-Targeting Lipid Nanocarrier for Treating Osteoporosis More Effectively

Correction: Optimization of a CE-ICP-MS/MS method for the investigation of liposome–cisplatin nanosystems and their interactions with transferrin

Correction: Oral delivery of a platinum anticancer drug using lipid assisted polymeric nanoparticles

Correction: Highly Penetrative Liposome Nanomedicine Generated by a Biomimetic Strategy for Enhanced Cancer Chemotherapy.

Correction: Al Khatib et al. Inhaled Medicines for Targeting Non-Small Cell Lung Cancer. Pharmaceutics 2024, 15, 2777

Correction: Optimization of Hydrophobic Nanoparticles to Better Target Lipid Rafts with Molecular Dynamics Simulations.

Correction: Simionescu et al. The Multifaceted Role of Extracellular Vesicles in Glioblastoma: microRNA Nanocarriers for Disease Progression and Gene Therapy. Pharmaceutics 2021, 13, 988

In vitro manipulation of mammalian preimplantation embryos can alter transcript abundance of histone variants and associated factors.

Correction to “Polymer-Mediated Drug Supersaturation Controlled by Drug–Polymer Interactions Persisting in an Aqueous Environment”

Erratum: Author correction to 'Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics' [Acta Pharm Sin B 12 (2022) 4458-4471]

Correction to "Computational Studies of Lipid Droplets"

Correction: Yang et al. Construction and Evaluation of Chitosan-Based Nanoparticles for Oral Administration of Exenatide in Type 2 Diabetic Rats. Polymers 2022, 14, 2181

Correction: Nordin et al. The State of the Art of Natural Polymer Functionalized Fe3O4 Magnetic Nanoparticle Composites for Drug Delivery Applications: A Review. Gels 2023, 9, 121

Correction to ‘Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy’

Erratum to: A novel GSH responsive poly(alpha-lipoic acid) nanocarrier bonding with the honokiol-DMXAA conjugate for combination therapy